Daymark Health: A New Dawn in Cancer Care
April 4, 2025, 9:32 pm
In the world of cancer care, change is often slow. But Daymark Health is here to flip the script. This Philadelphia-based company has just raised $11.5 million in seed funding, a shot in the arm for its ambitious mission. Co-led by Maverick Ventures and Yosemite, with support from Oncology Ventures, this funding will fuel Daymark's quest to redefine how cancer care is delivered.
Cancer is a relentless foe. Each year, nearly two million Americans hear the words, “You have cancer.” The journey that follows is often a lonely one. Patients spend over 8,500 hours outside the clinic, grappling with questions, symptoms, and urgent needs. It’s a daunting task, navigating a fragmented healthcare system. Daymark Health aims to change that narrative.
Founded by Dr. Justin Bekelman, Robert Pahlavan, and Jonathan Rhodes, Daymark Health is not just another healthcare startup. It’s a lifeline. The company launched operations this year, partnering with a leading payer in the Northeast. Their goal? To provide evidence-based, supportive cancer care to over 2,500 patients.
Daymark Health is built on a simple yet powerful idea: cancer care should be comprehensive and personalized. Their platform offers a blend of in-home and virtual support, ensuring that patients receive care tailored to their unique needs. It’s like having a safety net woven from the threads of clinical expertise, mental health support, and social assistance.
The company’s approach is holistic. It’s not just about treating the disease; it’s about caring for the person. Daymark’s team includes nurse practitioners, nurses, social workers, and health partners. Together, they work alongside patients’ oncologists and primary care providers. This collaborative model optimizes care delivery, making it seamless and effective.
With the recent funding, Daymark plans to expand its clinical team and accelerate the development of its platform. This means more resources to support patients and more partnerships with health plans across the country. The goal is clear: to redefine the cancer care experience.
The leadership team at Daymark is impressive. Roy Beveridge, former Chief Medical Officer of Humana and U.S. Oncology, serves as Executive Board Chair. Ezekiel Emanuel, a key architect of the Affordable Care Act, is the Clinical Advisory Board Chair. Their expertise will guide Daymark as it navigates the complex landscape of cancer care.
Despite advancements in treatment over the past 50 years, the healthcare system remains fragmented. Patients often find themselves lost in a maze of appointments and paperwork. Daymark Health seeks to eliminate this confusion. They aim to create a cohesive experience that empowers patients.
Imagine a world where cancer patients have 24/7 access to support. Where mental health assistance is just a click away. Where symptom management is proactive, not reactive. Daymark is working to make this vision a reality. Their personalized cancer care program is designed to provide navigation through the complexities of treatment.
The need for such a service is urgent. Cancer is not just a medical issue; it’s a social one. It affects families, friends, and communities. Daymark understands this. They recognize that cancer care is a collective effort. It takes a village to support a patient through this journey.
The funding will also allow Daymark to take on total cost of care risk contracts for health plans. This value-based care model shifts the focus from volume to value. It incentivizes quality care over quantity, ensuring that patients receive the best possible outcomes.
As Daymark Health sets out to redefine cancer care, they are not just looking at the immediate needs of patients. They are also focused on long-term solutions. By building partnerships with health plans and expanding their clinical team, they are laying the groundwork for sustainable change in the healthcare landscape.
The launch of Daymark Health is a beacon of hope. It signals a shift towards a more integrated and supportive approach to cancer care. With their innovative platform and dedicated team, they are poised to make a significant impact.
In a world where cancer often feels isolating, Daymark Health is a reminder that patients are not alone. They are part of a community that cares. This new model of care could very well set a new standard in oncology.
As the company moves forward, the eyes of the healthcare industry will be watching. Will Daymark Health succeed in its mission? Only time will tell. But one thing is certain: they are on a path to change the way we think about cancer care. And that’s a journey worth taking.
Cancer is a relentless foe. Each year, nearly two million Americans hear the words, “You have cancer.” The journey that follows is often a lonely one. Patients spend over 8,500 hours outside the clinic, grappling with questions, symptoms, and urgent needs. It’s a daunting task, navigating a fragmented healthcare system. Daymark Health aims to change that narrative.
Founded by Dr. Justin Bekelman, Robert Pahlavan, and Jonathan Rhodes, Daymark Health is not just another healthcare startup. It’s a lifeline. The company launched operations this year, partnering with a leading payer in the Northeast. Their goal? To provide evidence-based, supportive cancer care to over 2,500 patients.
Daymark Health is built on a simple yet powerful idea: cancer care should be comprehensive and personalized. Their platform offers a blend of in-home and virtual support, ensuring that patients receive care tailored to their unique needs. It’s like having a safety net woven from the threads of clinical expertise, mental health support, and social assistance.
The company’s approach is holistic. It’s not just about treating the disease; it’s about caring for the person. Daymark’s team includes nurse practitioners, nurses, social workers, and health partners. Together, they work alongside patients’ oncologists and primary care providers. This collaborative model optimizes care delivery, making it seamless and effective.
With the recent funding, Daymark plans to expand its clinical team and accelerate the development of its platform. This means more resources to support patients and more partnerships with health plans across the country. The goal is clear: to redefine the cancer care experience.
The leadership team at Daymark is impressive. Roy Beveridge, former Chief Medical Officer of Humana and U.S. Oncology, serves as Executive Board Chair. Ezekiel Emanuel, a key architect of the Affordable Care Act, is the Clinical Advisory Board Chair. Their expertise will guide Daymark as it navigates the complex landscape of cancer care.
Despite advancements in treatment over the past 50 years, the healthcare system remains fragmented. Patients often find themselves lost in a maze of appointments and paperwork. Daymark Health seeks to eliminate this confusion. They aim to create a cohesive experience that empowers patients.
Imagine a world where cancer patients have 24/7 access to support. Where mental health assistance is just a click away. Where symptom management is proactive, not reactive. Daymark is working to make this vision a reality. Their personalized cancer care program is designed to provide navigation through the complexities of treatment.
The need for such a service is urgent. Cancer is not just a medical issue; it’s a social one. It affects families, friends, and communities. Daymark understands this. They recognize that cancer care is a collective effort. It takes a village to support a patient through this journey.
The funding will also allow Daymark to take on total cost of care risk contracts for health plans. This value-based care model shifts the focus from volume to value. It incentivizes quality care over quantity, ensuring that patients receive the best possible outcomes.
As Daymark Health sets out to redefine cancer care, they are not just looking at the immediate needs of patients. They are also focused on long-term solutions. By building partnerships with health plans and expanding their clinical team, they are laying the groundwork for sustainable change in the healthcare landscape.
The launch of Daymark Health is a beacon of hope. It signals a shift towards a more integrated and supportive approach to cancer care. With their innovative platform and dedicated team, they are poised to make a significant impact.
In a world where cancer often feels isolating, Daymark Health is a reminder that patients are not alone. They are part of a community that cares. This new model of care could very well set a new standard in oncology.
As the company moves forward, the eyes of the healthcare industry will be watching. Will Daymark Health succeed in its mission? Only time will tell. But one thing is certain: they are on a path to change the way we think about cancer care. And that’s a journey worth taking.